Understood
This website is using cookies. More details
NEWS
Influenza – Rapid Diagnosis Improves Clinical Management

Influenza is an acute viral infection of the respiratory tract that can cause...
Read more >>

Standard F Fluorescent Immunoassay System

A new rapid, easy-to-use diagnostics platform for point of care use…
Read more >>

Oxford Biosystems launches Legionella Water test breakthrough at WMSoc Conference

Delegates at the Water Management Society (WMSoc) conference...
Read more >>

 Products Clinical-Solutions Haematology

HAEMATOLOGY

HaematologyOxford Biosystems works with three companies that offer innovative kits and instrumentation for the busy Haematology laboratory that needs fast, accurate results – Biomedomics (NC, USA), Alifax (Padova, Italy) and Viennalabs (Vienna, Austria).

SickleScan® Point of Care test

Sickle cell disease (SCD) is an inherited blood disorder which often causes red blood cells (RBCs) to become sickle-shaped through the presence of the abnormal haemoglobin S variant. Highly rigid sickle-shaped blood may have difficulty passing through small blood vessels, blocking the normal blood flow, damaging tissues, and ultimately leading to many of the complications of SCD. Additionally, RBCs containing mostly haemoglobin S live only about 16 days compared to 120 days for normal red blood cells. To initiate life-saving therapies, early diagnosis of SCD is key.

BioMedomics Sickle SCAN is a multiplexed, qualitative, point-of-care immunoassay to aid in the rapid diagnosis of sickle cell disorders

BioMedomics™ Sickle SCAN® is a multiplexed, qualitative, point-of-care immunoassay to aid in the rapid diagnosis of sickle cell disorders. The test is made up of three indicators which detect the presence of haemoglobins A, S, and C, allowing the user to rapidly distinguish between normal, carrier, and sickle cell disease samples. The test can be completed in 3 easy steps, giving real time results in under 5 minutes. It uses a small amount of whole blood from a fingerstick, heelstick, or venipuncture. A protocol for using blood spots is available on request.

The test is made up of three indicators which detect the presence of haemoglobins

ALIFAX® - ESR in 20 seconds

The erythrocyte sedimentation rate (ESR) is widely used as a screening or monitoring test for patients with acute or chronic inflammation. The reference technique for ESR is the Westergren method but this is time consuming and includes many variables that make quality control difficult such as sample collection, temperature and time of sample storage, equipment and methodology.

Capillary photometry technology incorporated by Alifax in their ESR analysers measures red blood cell aggregation, providing automated ESR results in 20 seconds and overcoming the variables and limitations of the sedimentation method.

  • Erythrocyte Sedimentation Rate Measurements by TEST 1 Better Reflect Inflammation Than Do Those by the Westergren Method in Patients With Malignancy, Autoimmune Disease, or Infection
  • Choong-Hwan Cha, MD et al

Alifax Latex Control kits contain three samples with known low, medium and high values, and are available in 2 pack sizes (6 tests and 30 tests)

Alifax ESR analysers provide results in 20 seconds with high correlation with the Westergren method.


Test 1

Advantages

Test 1 THL



Test 1 THL

Roller 20 PN

Advantages

roller 20pn



Code SI R20-PN

JO-PLUS

Advantages

 

 

JO-PLUS



JO-PLUS

Oxford Biosystems

184B Park Drive

Milton Park

Abingdon

Oxon

OX14 4SE

Oxford Biosystems has pledged to be an Antibiotic Guardian

Members of:

BIVDA Member 2019